Ozmosi | RYSW01 Drug Profile
Contact Us
Drug Profile
Using advanced filters...
Advanced Search [+]

RYSW01

Alternative Names: RYSW01, RY_SW01
Clinical Status: Active
Latest Update: 2024-07-08
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Cell Therapy

Novel Mechanism: No

Modality: Cell Therapy

Route of Administration: Injection

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Company: Jiangsu Renocell Biotech Company
Company Location: Asia Pacific
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for RYSW01

Countries in Clinic: China

Active Clinical Trial Count: 4

Recent & Upcoming Milestones

Highest Development Phases

Phase 2: Lupus Nephritis|Scleroderma, Diffuse

Phase 1: Scleroderma, General

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT06058091

 RYSW202301

P2

Recruiting

Scleroderma, Diffuse

2025-12-31

2024-01-19

Primary Endpoints|Treatments|Trial Status

NCT06058078

 RYSW202201

P2

Recruiting

Lupus Nephritis

2025-12-31

2024-01-19

NCT06489652

 RYSW202402

P1

Not yet recruiting

Scleroderma, Diffuse

2025-05-31

2024-07-09

Primary Endpoints|Treatments

CTR20242285

 CTR20242285

P1

Recruiting

Scleroderma, General

None

2025-05-17

Patient Enrollment|Start Date|Treatments|Trial Status

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions